3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
3
Neoplasms
2
Infertility
2
Fatigue
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sezary Syndrome
1
Sexual Dysfunction, Physiological
1
Sarcoma, Kaposi
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Leukemia, Prolymphocytic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
cedazuridine
1
Therapeutics
1
Interleukin-8
1
HuMax-IL8
1
Decitabine
1
DNA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Cytopenia
×
Therapeutics
×
Clear all
NCT02775383
2026-02-03
MDS
National Heart, Lung, and Blood Institute (NHLBI)
Completed
2,115 enrolled